Shanghai Rightongene Biotechnology Co., Ltd.

SHSE:688217 Stock Report

Market Cap: CN¥1.3b

Shanghai Rightongene Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 688217?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms5,642,40110.2%
Private Companies9,045,28416.4%
Institutions10,812,33619.6%
Individual Insiders11,103,38320.1%
General Public18,582,87133.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 66.17% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.4%
Hui Xiong
10,176,397CN¥231.3m0%no data
10.2%
Hangzhou Haoying Investment Management Partnership Enterprise (Limited Partnership)
5,642,401CN¥128.3m-8.99%no data
8.92%
Shanghai Boci Investment Partnership Enterprise (Limited Partnership)
4,924,723CN¥111.9m0%no data
3.62%
Shanghai Liyang Investment Partnership Enterprise (Limited Partnership)
2,000,000CN¥45.5m0%no data
2.8%
Rongtong Fund Management Co. Ltd.
1,547,163CN¥35.2m0%0.11%
2.66%
Tianjin Kangshi Yunda Medical Technology Development Partnership Enterprise (L.P.)
1,465,734CN¥33.3m0%no data
2.55%
E Fund Management Co., Ltd.
1,405,080CN¥31.9m0%no data
1.77%
CDBI Partners
978,101CN¥22.2m0%8.29%
1.69%
Shanghai Orient Securities Asset Management Co., Ltd.
933,408CN¥21.2m0%0.02%
1.66%
Shenzhen Gaotejia Hongrui Venture Capital Co., Ltd.
915,530CN¥20.8m0%no data
1.63%
Shenzhen Rising Future Private Securities Fund Management Co., Ltd.
901,000CN¥20.5m0%5.9%
1.61%
Jing Zhang
888,786CN¥20.2m0%no data
1.51%
GP Capital Co., Ltd.
833,541CN¥18.9m0%1.58%
1.26%
Beijing Rongchen Houji Investment Management Co., Ltd.
692,814CN¥15.7m0%16.03%
1.19%
Euro Right Limited
654,827CN¥14.9m0%no data
1.13%
Hangzhou Beijia Investment Management Co., Ltd.
625,160CN¥14.2m0%no data
0.97%
Shanghai HFT Fortune Asset Management Co., Ltd.
537,301CN¥12.2m0%100.0%
0.79%
Gfund Management Co., Ltd.
435,364CN¥9.9m0%0.04%
0.44%
Chongqing GTJA Equity Investment Fund Management Co., Ltd.
242,524CN¥5.5m0%10.5%
0.37%
Goldstate Capital Fund Management Co., Ltd.
206,286CN¥4.7m0%0.07%
0.37%
China Asset Management Co. Ltd.
202,810CN¥4.6m0%no data
0.31%
Dacheng Fund Management Co., Ltd.
170,343CN¥3.9m0%no data
0.15%
Huatai-PineBridge Fund Management Co., Ltd.
85,200CN¥1.9m0%no data
0.06%
Fullgoal Fund Management Co. Ltd.
33,142CN¥753.3k0%no data
0.032%
Junyan He
17,600CN¥400.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 12:41
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Rightongene Biotechnology Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xiao Wei LinEverbright Securities Co. Ltd.